Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma

References

• Dayan, CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996;335:99–107.
   PubMed Web of Science ®Google Scholar
• Weetman AP. Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum. Clin Endocrinol (Oxford), 2010, [Epub ahead of print], doi:10.1111/j.1365-2265.2010.03855.x.
   Google Scholar
• Mavragani CP, Danieledes S, Moutsopoulos HM. Systemic autoimmune manifestations: when should underlying thyroid autoimmunity be considered? Curr Rheumatol Rev 2006;2:345–8.
   Google Scholar
• Mavragani CP, Skopouli FN, Moutsopoulos HM. Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndrome. J Rheumatol 2009;36:1626–30.
   PubMed Web of Science ®Google Scholar
• Mavragani CP, Ioannidis JP, Tzioufas AG, Hantoumi IE, Moutsopoulos HM. Recurrent pregnancy loss and autoantibody profile in autoimmune diseases. Rheumatology (Oxford) 1999;38:1228–33.
   PubMed Web of Science ®Google Scholar
• Mavragani CP, Patronas N, Dalakas M, Moutsopoulos HM. Ill-defined neurological syndromes with autoimmune background: a diagnostic challenge. J Rheumatol 2007;34:341–5.
   PubMed Web of Science ®Google Scholar
• Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009;38:369–74.
   PubMed Web of Science ®Google Scholar
• Takada K, Suzuki K, Matsumoto M, Okada M, Nakanishi T, Horikoshi H, Clinical characteristics of patients with both anti-U1RNP and anti-centromere antibodies. Scand J Rheumatol 2008;37:360–4.
   PubMed Web of Science ®Google Scholar
• Rojas-Villarraga A, Toro CE, Espinosa G, Rodríguez-Velosa Y, Duarte-Rey C, Mantilla RD, Factors influencing polyautoimmunity in systemic lupus erythematosus. Autoimmun Rev 2010;9:229–32.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Fallahi P, Mosca M, Ferrari SM, Ruffilli I, Corti A, Prevalence of thyroid dysfunctions in systemic lupus erythematosus. Metabolism 2010;59:896–900.
   PubMed Web of Science ®Google Scholar
• Del Puente A, Savastano S, Nuzzo V, Esposito A, Lupoli G. High prevalence of thyroid autoantibodies in newly diagnosed rheumatoid arthritis patients. Clin Exp Rheumatol 2003;21:137.
   PubMed Web of Science ®Google Scholar
• Zeher M, Horvath IF, Szanto A, Szodoray P. Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren’s syndrome. Thyroid 2009;19:39–45.
   PubMed Web of Science ®Google Scholar
• Ranque B, Berezne A, Le-Guern V, Pagnoux C, Allanore Y, Launay D, Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features. Scand J Rheumatol 2010;39:498–505.
   PubMed Web of Science ®Google Scholar
• Tsifetaki N, Georgiadis AN, Alamanos Y, Fanis S, Argyropoulou MI, Drosos AA. Subclinical atherosclerosis in scleroderma patients. Scand J Rheumatol 2010;39:326–9.
   PubMed Web of Science ®Google Scholar
• Mok MY, Chiu SS, Lo Y, Mak HK, Wong WS, Khong PL, Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis. Scand J Rheumatol 2009;38:381–5.
   PubMed Web of Science ®Google Scholar
• Shah AA, Wigley FM. Often forgotten manifestations of systemic sclerosis. Rheum Dis Clin North Am 2008;34:221–38.
   PubMed Web of Science ®Google Scholar
• Gordon MB, Klein I, Dekker A, Rodnan GP, Medsger TA Jr. Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism. Ann Intern Med 1981;95:431–5.
   PubMed Web of Science ®Google Scholar
• Innocencio RM, Romaldini JH, Ward LS. High prevalence of thyroid autoantibodies in systemic sclerosis and rheumatoid arthritis but not in the antiphospholipid syndrome. Clin Rheumatol 2003;22:494.
   PubMed Web of Science ®Google Scholar
• Kahl LE, Medsger TA Jr, Klein I. Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma). J Rheumatol 1986;13:103–7.
   PubMed Web of Science ®Google Scholar
• De Keyser L, Narhi DC, Furst DE, Huberman AK, Ross R, Clements J, Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis. J Endocrinol Invest 1990;13:161–9.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Ferri C, Fallahi P, Cazzato M, Ferrari SM, Sebastiani M, Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol 2007;156:431–7.
   PubMed Web of Science ®Google Scholar
• Marasini B, Ferrari PA, Solaro N, Selmi C, Marasini B, Ferrari PA, Thyroid dysfunction in women with systemic sclerosis. Ann N Y Acad Sci 2007;1108:305–11.
   PubMed Web of Science ®Google Scholar
• Molnar I, Balazs C, Szabo E, Czirjak L. Anti-thyroid antibodies and hypothyroidism in systemic sclerosis. Endocrinol Invest 1992;15:311.
   PubMed Web of Science ®Google Scholar
• Hudson M, Rojas-Villarraga A, Coral-Alvarado P, Lopez-Guzman S, Mantilla RD, Chalem P, Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun 2008;31:156–9.
   PubMed Web of Science ®Google Scholar
• Avouac J, Airo P, Dieude P, Caramaschi P, Tiev K, Diot E, Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J Rheumatol 2010;37:608–14.
   PubMed Web of Science ®Google Scholar
• Balbi G, Ferrera F, Rizzi M, Piccioli P, Morabito A, Cardamone L, Association of –318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. Clin Exp Immunol 2007;149:40–7.
   PubMed Web of Science ®Google Scholar
• Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001;44:735–6.
   PubMed Web of Science ®Google Scholar
• Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology. Br Med J 1996;313:539–44.
   PubMed Web of Science ®Google Scholar
• Drosos AA, Pennec YL, Elisaf M, Lamour A, Acritidis NC, Jouquan JR, Sjögren’s syndrome in patients with the CREST variant of progressive systemic scleroderma. J Rheumatol 1991;18:1685–8.
   PubMed Web of Science ®Google Scholar
• Badesch DB, Wynne KM, Bonvallet S, Voelkel NF, Ridgway C, Groves BM. Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link? Ann Intern Med 1993;119:44–6.
   PubMed Web of Science ®Google Scholar